Inhibiting the hormone somatostatin may be a new treatment strategy to prevent dangerous blood glucose drops in type 1 diabetes. This has been shown by a study conducted by the University of Gothenburg and other institutions. The proposed strategy is said to have the potential to save lives.
Medical Xpress – latest medical and health news stories
